Since 3KDS is toxic and tumor cells depend on KDSR activity to maintain 3KDS homeostasis, these authors have suggested that the overexpression of SPT can be exploited to selectively poison cancer cells and KDSR was indicated as a potential therapeutic target for the development of specific inhibitors. The gene discussed is KDSR; the disease is cancer.